phenidone has been researched along with Experimental Mammary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldossary, SA; Ansari, MN; Gautam, S; Kaithwas, G; Rani, S; Saeedan, AS | 1 |
1 other study(ies) available for phenidone and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Effects of phenidone (DuCLOX-2/5 inhibitor) against N-methyl-N-nitrosourea induced mammary gland carcinoma in albino rats.
Topics: Animals; Arachidonate 5-Lipoxygenase; Cyclooxygenase 2 Inhibitors; Female; Lipoxygenase Inhibitors; Mammary Neoplasms, Experimental; Methylnitrosourea; Pyrazoles; Random Allocation; Rats; Rats, Wistar; Treatment Outcome | 2018 |